In Vitro Anti-proliferative and Anti-invasive Effect of Polysaccharide-rich Extracts from Trametes Versicolor and Grifola Frondosa in Colon Cancer Cells

por Roca-Lema, Daniel, Martinez-Iglesias, Olaia, Fernández de Ana Portela, Catalina, Rodríguez-Blanco, Arturo, Valladares-Ayerbes, Manuel, Díaz-Díaz, Andrea, Casas-Pais, Alba, Prego, Cecilia, Figueroa, Angélica
Publicado 2019

Hakai reduces cell-substratum adhesion and increases epithelial cell invasion

por Rodríguez-Rigueiro, Teresa, Valladares-Ayerbes, Manuel, Haz-Conde, Mar, Aparicio, Luis A, Figueroa, Angélica
Publicado 2011

Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving...

por Taieb, Julien, Rivera, Fernando, Siena, Salvatore, Karthaus, Meinolf, Valladares-Ayerbes, Manuel, Gallego, Javier, Geissler, Michael, Koukakis, Reija, Demonty, Gaston, Peeters, Marc
Publicado 2017

Exploratory pooled analysis evaluating the effect of sequence of biological therapies on overall survival in patients with RAS wild-type metastatic colorectal carcinoma

por Peeters, Marc, Forget, Frédéric, Karthaus, Meinolf, Valladares-Ayerbes, Manuel, Zaniboni, Alberto, Demonty, Gaston, Guan, Xuesong, Rivera, Fernando
Publicado 2018

Circulating miR-200c and miR-141 and outcomes in patients with breast cancer

por Antolín, Silvia, Calvo, Lourdes, Blanco-Calvo, Moisés, Santiago, María Paz, Lorenzo-Patiño, María José, Haz-Conde, Mar, Santamarina, Isabel, Figueroa, Angélica, Antón-Aparicio, Luis Miguel, Valladares-Ayerbes, Manuel
Publicado 2015

A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients

por Elez, Elena, Pericay, Carles, Valladares-Ayerbes, Manuel, Bando, Inmaculada, Safont, Maria Jose, Gallego, Javier, Grávalos, Cristina, Arrivi, Antonio, Carrato, Alfredo, Conde, Verónica, Ortiz, Maria José, López, Carlos, Alonso, Beatriz, Ruiz de Mena, Inmaculada, Díaz-Rubio, Eduardo, Tabernero, Josep, Aranda, Enrique
Publicado 2019

Diagnosis delay and follow-up strategies in colorectal cancer. Prognosis implications: a study protocol

por Pita Fernández, Salvador, Pértega Díaz, Sonia, López Calviño, Beatriz, González Santamaría, Paloma, Seoane Pillado, Teresa, Arnal Monreal, Francisco, Maciá, Francesc, Sánchez Calavera, María Antonia, Espí Macías, Alejandro, Valladares Ayerbes, Manuel, Pazos, Alejandro, Reboredo López, Margarita, González Saez, Luis, Ramos Montserrat, María, Segura Noguera, Josep María, Monreal Aliaga, Isabel, González Luján, Luis, Martín Rabadán, María, Murta Nascimento, Cristiane, Pueyo, Olga, Boscá Watts, Marta Maia, Cabeza Irigoyen, Elena, Casmitjana Abella, Montserrat, Pinilla, Marina, Costa Alcaraz, Ana, Ruiz Torrejón, Amador, Burón Pust, Andrea, García Aranda, Concepción, de Lluc Bennasar, María, Lafita Mainz, Sergio, Novella, Maite, Manzano, Hermini, Vadell, Catalina, Falcó, Esther, Esteva, Magdalena
Publicado 2010

Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study

por Valladares-Ayerbes, Manuel, Garcia-Alfonso, Pilar, Muñoz Luengo, Jorge, Pimentel Caceres, Paola Patricia, Castillo Trujillo, Oscar Alfredo, Vidal-Tocino, Rosario, Llanos, Marta, Llorente Ayala, Beatriz, Limon Miron, Maria Luisa, Salud, Antonieta, Cirera Nogueras, Luis, Garcia-Carbonero, Rocio, Safont, Maria Jose, Falco Ferrer, Esther, Aparicio, Jorge, Vicente Conesa, Maria Angeles, Guillén-Ponce, Carmen, Garcia-Teijido, Paula, Medina Magan, Maria Begoña, Busquier, Isabel, Salgado, Mercedes, Lloansí Vila, Ariadna
Publicado 2022

First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis

por García-Alfonso, Pilar, Díaz-Rubio, Eduardo, Abad, Albert, Carrato, Alfredo, Massutí, Bartomeu, Ortiz-Morales, María José, Manzano Mozo, José Luis, Muñoz, Andrés, Durán, Gema, Sastre, Javier, Safont, María José, Ferreiro, Reyes, Rivera, Fernando, González, Encarnación, Valladares-Ayerbes, Manuel, Grávalos, Cristina, Alonso-Orduña, Vicente, Viéitez, José María, Yubero, Alfonso, Aranda, Enrique
Publicado 2021

Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma...

por Sastre, J., García-Alfonso, P., Viéitez, J.M., Cano, M.T., Rivera, F., Reina-Zoilo, J.J., Salud-Salvia, A., Quintero, G., Robles-Díaz, L., Safont, M.J., La Casta, A., Gil, S., Polo, E., Asensio-Martínez, E., García-Paredes, B., López, R.L., Guillot, M., Valladares-Ayerbes, M., Aranda, E., Díaz-Rubio, E.
Publicado 2021